Synapse - Gregory Riely

Results (219)

Clinical and genomic features of response and toxicity to sotorasib in a real-world cohort of patients with advanced KRAS G12C-mutant non-small cell lung cancer

Journal Article

Thummalapalli, R.; Bernstein, E.; Herzberg, B.; Li, B. T.; Iqbal, A.; Preeshagul, I.; Santini, F. C.; Eng, J.; Ladanyi, M.; Yang, S. R.; more...
JCO Precision Oncology (2023)

Fulltext@MSK | Save

Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry

Meeting Abstract

Fong, C. J.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D. R.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; Mastrogiacomo, B.; more...
Cancer Research (2023)

Fulltext@MSK | Save

Analysis and visualization of longitudinal genomic and clinical data from the AACR Project GENIE Biopharma Collaborative in cBioPortal

Journal Article

de Bruijn, I.; Kundra, R.; Mastrogiacomo, B.; Tran, T. N.; Sikina, L.; Mazor, T.; Li, X.; Ochoa, A.; Zhao, G.; Lai, B.; more...
Cancer Research (2023)

Fulltext@MSK | Save

Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer

Journal Article

Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
The Oncologist (2023)

Fulltext@MSK | Save

Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non–small cell lung cancer

Journal Article

Thummalapalli, R.; Ricciuti, B.; Bandlamudi, C.; Muldoon, D.; Rizvi, H.; Elkrief, A.; Luo, J.; Alessi, J. V.; Pecci, F.; Lamberti, G.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Understanding genomic and social determinants of cancer immunotherapy outcome across ancestry

Meeting Abstract

Carrot-Zhang, J.; Fong, C.; Waters, M.; Pichotta, K.; Jee, J.; Jutagir, D.; Ma, D.; Perea-Chamblee, T.; Kim, S.; Arora, K.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

Clinical characteristics and outcomes of patients with EGFR-mutant lung cancer with acquired BRAF alterations

Meeting Abstract

Sui, J.; Yang, S. R.; Bowman, A. S.; Vankayala, P.; Falcon, C.; Somwar, R.; Drilon, A. E.; Riely, G. J.; Kris, M. G.; Ladanyi, M.; more...
Journal of Thoracic Oncology (2023)

Fulltext@MSK | Save

The GENIE BPC NSCLC cohort: A real-world repository integrating standardized clinical and genomic data for 1,846 patients with non-small cell lung cancer

Journal Article

Choudhury, N. J.; Lavery, J. A.; Brown, S.; de Bruijn, I.; Jee, J.; Tran, T. N.; Rizvi, H.; Arbour, K. C.; Whiting, K.; Shen, R.; more...
Clinical Cancer Research (2023)

Fulltext@MSK | Save

Clinical outcomes and genomic landscape of patients (pts) with EGFR-mutant lung cancer (EGFR+ LC) with central nervous system (CNS) metastases (mets)